Gerald S. Brenner
12Patents
6h-index
24Co-inventors
66Inventor score
Filing activity: Aug 28, 1978 → Sep 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5462932A | Oral liquid alendronate formulations | Human Necessities | 43 | Expired |
| US5356887A | Pharmaceutical compositions containing insoluble calcium salts of amino-hydroxybutylidene bisphoshonic acids | Human Necessities | 19 | Expired |
| US5849726A | Anhydrous alendronate monosodium salt formulations | Chemistry; Metallurgy | 18 | Expired |
| US4190655A | Amiloride citrate | Chemistry; Metallurgy | 15 | Expired |
| US5780455A | Intravenous alendronate formulations | Human Necessities | 11 | Expired |
| US6008207A | Anhydrous alendronate monosodium salt formulations | Human Necessities | 7 | Expired |
| US5843924A | Intravenous alendronate formulations | Human Necessities | 3 | Expired |
| US11091505B2 | Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof | Human Necessities | 2 | Active |
| US5914323A | Intravenous alendronate formulations | Human Necessities | 2 | Expired |
| US11820784B2 | Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof | Human Necessities | 1 | Active |
| US12187752B2 | Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof | Human Necessities | 0 | Active |
| US5693812A | Polymorphic forms of an angiotensin II antagonist | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.